Perlara in the news
November 1, 2017
Perlara Announces $7.4M Equity Financing
January 31, 2017
Perlara Announces Third Patient Advocacy Group Partnership
January 10, 2017
Perlara PBC Announces Patient Advocacy Group Partnerships
July 31, 2014
Perlstein Lab Seed Round
The latest from our Blog
Earlier this week I was alerted on Twitter (where else?) to a new NGLY1 paper from Dr. Clement Chow’s lab at the University of Utah entitled: “Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic...
When we last checked in a year ago, Perlara had just achieved three critical milestones: a product (PerlQuest), a validating Pharma deal, and first revenue - a small check, but revenue nonetheless. Over the course of 2017, we transitioned from startup with a...
The Condition: Mucolipidosis Type IV Mucolipidosis is a group of inherited lysosomal storage disorders characterized by aberrant storage and accumulation of lipid vesicles in patient cells. Mucolipidosis type IV (MLIV) is a rare genetic lysosomal storage disorder...